levonorgestrel has been researched along with Intellectual Disability in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Cereijo, R; de Zegher, F; García-Beltran, C; Ibáñez, L; López-Bermejo, A; Malpique, R; Quesada-López, T; Villarroya, F | 1 |
Dempster-Rivett, K; Smalldridge, J | 1 |
Aslam, N; Blunt, S; Latthe, P | 1 |
1 trial(s) available for levonorgestrel and Intellectual Disability
Article | Year |
---|---|
Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization.
Topics: Adipocytes; Adipogenesis; Adipose Tissue, Brown; Adolescent; Arrhythmias, Cardiac; Biomarkers; Chemokines, CXC; Contraceptives, Oral, Hormonal; Drug Therapy, Combination; Ethinyl Estradiol; Female; Gene Expression; Genetic Diseases, X-Linked; Gigantism; Heart Defects, Congenital; Humans; Hypoglycemic Agents; Insulin Resistance; Intellectual Disability; Levonorgestrel; Metformin; Mineralocorticoid Receptor Antagonists; Pioglitazone; Polycystic Ovary Syndrome; Spironolactone; Treatment Outcome | 2020 |
2 other study(ies) available for levonorgestrel and Intellectual Disability
Article | Year |
---|---|
Management of menstrual difficulties in adolescents with physical and intellectual disabilities at a New Zealand tertiary hospital.
Topics: Adolescent; Cohort Studies; Disabled Persons; Female; Humans; Intellectual Disability; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation Disturbances; New Zealand; Retrospective Studies; Tertiary Care Centers | 2016 |
Effectiveness and tolerability of levonorgestrel intrauterine system in adolescents.
Topics: Adolescent; Contraceptive Agents, Female; Drug Resistance; Dysmenorrhea; Female; Follow-Up Studies; Humans; Intellectual Disability; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Quality of Life; Treatment Outcome | 2010 |